Spravato (Esketamine)
Parker Neuroscience is in-network with UnitedHealthcare and Optum for Spravato treatment. Spravato is FDA-approved for treatment-resistant depression and is administered in our office under clinical supervision.
Coverage details vary by plan, and Spravato typically requires prior authorization. Before treatment begins, we verify your benefits and walk you through any out-of-pocket costs.